Abstract:Poly(ADP-ribosyl) ation is a reversible post-translational protein modification implicated in the regulation of a number of biological functions. Whereas an 18 member superfamily of poly(ADP-ribose) polymerase (PARP) enzymes synthesize poly(ADP-ribose) (PAR), a single protein, PAR glycohydrolase (PARG) is responsible for the catabolism of the polymer. PARP-1 accounts for more than 90% of the poly(ADP-ribosyl)ating capacity of the cells. PARP-1 activated by DNA breaks cleaves NAD(+) into nicotinamide and ADP-ribose and uses the latter to synthesize long branching PAR polymers covalently attached to acceptor proteins including histones, DNA repair enzymes, transcription factors and PARP-1. Whereas activation of PARP-1 by mild genotoxic stimuli may facilitate DNA repair and cell survival, irreparable DNA damage triggers apoptotic or necrotic cell death. In apoptosis, early PARP activation may assist the apoptotic cascade [e.g. by stabilizing p53, by mediating the translocation of apoptosis inducing factor (AIF) from the mitochondria to the nucleus or by inhibiting early activation of DNases]. In most severe oxidative stress situations, excessive DNA damage causes over activation of PARP-1, which incapacitates the apoptotic machinery and switches the mode of cell death from apoptosis to necrosis. Besides serving as a cytotoxic mediator, PARP-1 is also involved in transcriptional regulation, most notably in the NF kappaB and AP-1 driven expression of inflammatory mediators. Pharmacological inhibition or genetic ablation of PARP-1 provided remarkable protection from tissue injury in various oxidative stress-related disease models ranging from stroke, diabetes, diabetic endothelial dysfunction, myocardial ischemia-reperfusion, shock, Parkinson's disease, arthritis, colitis to dermatitis and uveitis. These beneficial effects are attributed to inhibition of the PARP-1 mediated suicidal pathway and to reduced expression of inflammatory cytokines and other mediators (e.g. inducible nitric oxide synthase).

The Role of PARP-1 in Host-Pathogen Interaction and Cellular Stress Responses.

Human PARP1 Substrates and Regulators of Its Catalytic Activity: an Updated Overview.

PARP1: Liaison of Chromatin Remodeling and Transcription

Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies

PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities

Transcriptional Roles of PARP1 in Cancer

The role of PARP1 in the DNA damage response and its application in tumor therapy

The dynamics and Regulation of PARP1 and PARP2 in response to DNA damage and during replication

Functional Aspects of PARP1 in DNA Repair and Transcription

Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: past, present, and future

Data from PARP1-Driven Poly-ADP-Ribosylation Regulates BRCA1 Function in Homologous Recombination–Mediated DNA Repair

The multifaceted roles of PARP1 in DNA repair and chromatin remodelling

PARP1 inhibition enhances reactive oxygen species on gut microbiota

PARP1: A Promising Target for the Development of PARP1-based Candidates for Anticancer Intervention

PARP1 as an Epigenetic Modulator: Implications for the Regulation of Host-Viral Dynamics

PARP7 and nucleic acid-driven oncosuppression

Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases

Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs

The role of PARP1 in neurodegenerative diseases and aging

The expanding universe of PARP1-mediated molecular and therapeutic mechanisms